ROIV compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ROIVRoivant Sciences Ltd.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ROIVRoivant Sciences Ltd.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ROIV 6

IMVTImmunovantcustomer

—HanAll Biopharmaunlistedsupplier

—Sumitomo Pharmaunlistedsupplier

—Bayerunlistedsupplier

2 more · ROIV chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

ROIVRoivant Sciences Ltd.

38.90▲+6.23%· post 38.88· delayed

Mkt cap$26.5BRevenue$1MQ1 FY26Revenue$8MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,360.49· delayed

After hoursNov 6 '26delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 6 '26delayed

ROIVRoivant Sciences Ltd.

LLYELI Lilly & Co

38.90▲+6.23%post 38.88delayed

Price

1,360.90▼−0.28%post 1,360.49delayed

$26.5B

Mkt cap

$1.2T

Q1 FY26$1M

Revenue

$24.4BQ3 FY26

FY25$8M

Revenue

$65.2BFY25

ROIV38.90▲+6.23%vsLLY1,360.90▼−0.28%After hoursNov 6 '26delayed